Caidya & Simbec-Orion announce strategic combination.
Learn More
About
Company Overview
Leadership Team
Board of Directors
Global Presence
Clinical Technology & Ecosystem
AI Principles
ESG
Participating in Clinical Trials
Therapeutics
Therapeutic Expertise
Oncology & Hematology
Cardiovascular-Metabolic
Rare Disease
Pediatrics
Gastroenterology
Nephrology
Dermatology
Ophthalmology
Cell & Gene Therapy
Neurology
Immunology
Infectious Disease
Clinical
Clinical Development Strategy
Early Phase Development
Phase II/III
Regulatory Strategy
Medical Affairs
Post-Marketing Solutions
Clinical Trial Delivery
Clinical Operations
Study Start-Up
Trial Feasibility
Project Management
RBQM
Medical Monitoring
Clinical Data Management
Biometrics
Medical Writing
Regulatory Services
Pharmacovigilance
Quality Assurance
Service Models
Resources
Resource Center
Blog
News
Events
Careers
Contact Us
About
Company Overview
Leadership Team
Board of Directors
Global Presence
Clinical Technology & Ecosystem
AI Principles
ESG
Participating in Clinical Trials
Therapeutics
Therapeutic Expertise
Oncology & Hematology
Cardiovascular-Metabolic
Rare Disease
Pediatrics
Gastroenterology
Nephrology
Dermatology
Ophthalmology
Cell & Gene Therapy
Neurology
Immunology
Infectious Disease
Clinical
Clinical Development Strategy
Early Phase Development
Phase II/III
Regulatory Strategy
Medical Affairs
Post-Marketing Solutions
Clinical Trial Delivery
Clinical Operations
Study Start-Up
Trial Feasibility
Project Management
RBQM
Medical Monitoring
Clinical Data Management
Biometrics
Medical Writing
Regulatory Services
Pharmacovigilance
Quality Assurance
Service Models
Resources
Resource Center
Blog
News
Events
Careers
Contact Us
Contact Us
Caidya & Simbec-Orion announce strategic combination.
Learn More
About
Company Overview
Leadership Team
Board of Directors
Global Presence
Clinical Technology & Ecosystem
AI Principles
ESG
Participating in Clinical Trials
Therapeutics
Therapeutic Expertise
Oncology & Hematology
Cardiovascular-Metabolic
Rare Disease
Pediatrics
Gastroenterology
Nephrology
Dermatology
Ophthalmology
Cell & Gene Therapy
Neurology
Immunology
Infectious Disease
Clinical
Clinical Development Strategy
Early Phase Development
Phase II/III
Regulatory Strategy
Medical Affairs
Post-Marketing Solutions
Clinical Trial Delivery
Clinical Operations
Study Start-Up
Trial Feasibility
Project Management
RBQM
Medical Monitoring
Clinical Data Management
Biometrics
Medical Writing
Regulatory Services
Pharmacovigilance
Quality Assurance
Service Models
Resources
Resource Center
Blog
News
Events
Careers
Contact Us
About
Company Overview
Leadership Team
Board of Directors
Global Presence
Clinical Technology & Ecosystem
AI Principles
ESG
Participating in Clinical Trials
Therapeutics
Therapeutic Expertise
Oncology & Hematology
Cardiovascular-Metabolic
Rare Disease
Pediatrics
Gastroenterology
Nephrology
Dermatology
Ophthalmology
Cell & Gene Therapy
Neurology
Immunology
Infectious Disease
Clinical
Clinical Development Strategy
Early Phase Development
Phase II/III
Regulatory Strategy
Medical Affairs
Post-Marketing Solutions
Clinical Trial Delivery
Clinical Operations
Study Start-Up
Trial Feasibility
Project Management
RBQM
Medical Monitoring
Clinical Data Management
Biometrics
Medical Writing
Regulatory Services
Pharmacovigilance
Quality Assurance
Service Models
Resources
Resource Center
Blog
News
Events
Careers
Contact Us
Contact Us
Access the Clinical Trials Resources
Most Relevant to Your Needs
Regulatory Update
Global Regulatory Updates on Clinical Trials (August 2026)
Article
“Success in APAC region requires local knowledge and globally consistent execution”
Quick Guide
A Practical Playbook for Chinese Biotech to Accelerate Successful EU Clinical Development
Case Study
Accelerating Dose Escalation in a High-Demand Oncology Study
Case Study
Delivering a Complex First-in-Human Study for a Potential Schizophrenia Treatment
Case Study
Accelerating a First-in-Human Study into Rare Disease Clinical Development
Case Study
Accelerating an Ultra-Rare Pediatric Study from Observation to Intervention
Case Study
Clinical Pharmacology Strategy Accelerates IPF Development
Case Study
Adaptive Trial Design Accelerates IPF Development
Case Study
Gamma Scintigraphy Demonstrates Effective Lung Deposition
Video
Looking Ahead: An Agile Global Partner from Early Development Through Registration
Video
Confidence in complexity: Caidya and Simbec-Orion strategic combination
Video
Stronger not larger: Caidya and Simbec-Orion strategic combination
Video
Transitioning from Phase I: Caidya and Simbec-Orion strategic combination
Video
Clinical pharmacology: Caidya and Simbec-Orion strategic combination
Video
Differentiated expertise: Caidya and Simbec-Orion strategic combination
Video
Client benefits: Caidya and Simbec-Orion strategic combination
Video
Cultural Fit: Shared Values Across Caidya and Simbec-Orion